Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2016/10/007389
CTRI/2016/10/007389
Completed
Phase 1

An open clinical trial for the assessment of efficacy of Pankajakasthuri Breath Eazy Mishrit in patients with Bronchial Asthma.

Pankajakasthuri Ayurveda Medical College and Post Graduate Centre0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J454- Moderate persistent asthmaHealth Condition 3: null- The Patients with Bronchial Asthma visiting PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE OUT PATIENT DEPARATMENTS for consultation.

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J454- Moderate persistent asthmaHealth Condition 3: null- The Patients with Bronchial Asthma visiting PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE OUT PATIENT DEPARATMENTS for consultation.
Sponsor
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre
Enrollment
60
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre

Eligibility Criteria

Inclusion Criteria

  • •Both sex with equal distributor with or without rhinitis.
  • •3 Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
  • •Asthmatic meet reversibility criteria (15% improvement in FEVI after Beta â?? 2 agonist inhalation)

Exclusion Criteria

  • •Mild intermittent, moderate persistent, severe persistent to severe Asthma (As per WHO GINA guidlines of duration more than 6 months)
  • •Dyspnoea due to other disease like Left ventricular failure, COPD (Chronic Bronchitis, Emphysema), Upper respiratory tract obstruction, Bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational Lung disease, tropical pulmonary eosinophilia, Lofflers disease \& Allergic Bronchopulmonary Aspergillosis etc.
  • •Diabetes Mellitus and Hypertension.
  • •Severe renal/Hepatic disease
  • •HIV positive cases
  • •Lung Cancer
  • •Pregnant/lactating mother
  • •Patient who need Salbutamol inhaler daily.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
A clinical trial to study the effect of Pankajakasthuri Orthoherb Tablet in patients with pain, swelling and stiffness of joints.
CTRI/2018/02/012189PANKAJAKASTHURI AYURVEDA MEDICAL COLEGE AND POST GRADUATE CENTER500
Not yet recruiting
Phase 2
Gandhaga Mezhugu for treating Urinaray infectioHealth Condition 1: N390- Urinary tract infection, site notspecified
CTRI/2023/09/057245ational Institute of Siddha
Not yet recruiting
Not Applicable
To Evaluate The Effectiveness Of Naaku Poochi Kudineer Chooranam ForThe Management Of Worm Infestation(Naaku Poochi Noi)In ChildreHealth Condition 1: A00-B99- Certain infectious and parasitic diseases
CTRI/2024/05/067427ational Institute Of Siddha
Not yet recruiting
Phase 2
To evaluate the clinical efficacy of Kottai Karanthai Chooranam (Internal), Semparuthi Poo Ennai (External) and Yoga Therapy for the treatment of Kalanjaga Padai (Psoriasis)Health Condition 1: null- Patients Suffering from Psoriasis
CTRI/2018/05/013972illy Shekenah B
Not yet recruiting
Phase 3
A clinical trial to study the effect of Swarnakshiryadi yog in the management of HyperbilirubinaemiaHealth Condition 1: R17- Unspecified jaundice
CTRI/2024/06/069642R. A. Podar Govt. Ayurvedic college